Clinical Trial Update: Scopolamine Treatment for Patients With Organophosphate Poisoning [NA]

View source ↗

Summary

The clinical trial evaluating scopolamine for organophosphate-induced neurotoxicity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organophosphate Poisoning

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Neurotoxicity Syndromes | NA | Status: WITHDRAWN